Lifebit’s Post

Today is World Afib Awareness Day, and September is National Atrial Fibrillation Awareness Month. It's important to highlight this condition in order to better understand the causes, symptoms, and risks that impact so many. Atrial fibrillation affects millions and can lead to serious health complications. Awareness and education are crucial for prevention and management. Let’s work together to support research, innovation, and patient care in the field of cardiology. To learn more about Atrial Fibrillation, visit this page: https://loom.ly/U235Ehg #AfibAwareness #HealthcareInnovation #Cardiology

To appropriately address gender inequities in cardiovascular health, cardiologists should recognize that psychosocial stress negatively affects cardiovascular health and is unequally distributed between men and women, a new review reports. Read more on #CRTonline. https://ow.ly/kHTE50SGn5H #cardiacnurse #cardiologists #cardiology #cardiologyfellow #cardiologyfellows #cardiologynurse #cardiologynurses #cathlab #cathlabnurse #cathlabtech #interventionalcardiologists #interventionalcardiology #interventionalcardiologyfellow #interventionalcardiologyfellows #MCRN #medicalequity

More than 22 million Americans living in rural and socioeconomically disadvantaged counties have no access to cardiologists, despite having a greater burden of cardiovascular disease, according to data reported in a new research letter. Read more on #CRTonline. https://ow.ly/QMO950SNrfS #cardiacnurse #cardiologists #cardiology #cardiologyfellow #cardiologyfellows #cardiologynurse #cardiologynurses #cathlab #cathlabnurse #cathlabtech #interventionalcardiologists #interventionalcardiology #interventionalcardiologyfellow #interventionalcardiologyfellows #MCRN #medicalequity #ruralhealth

🧬 Rethinking Heart Attack Treatment: Beta-Blockers' Role in Question👨⚕️ Have beta-blockers met their match? A recent study throws a curveball in the game of post-heart attack care. Published in the "New England Journal of Medicine," this extensive research, surprisingly, found long-term beta-blocker therapy didn't cut the mustard in reducing death or the risk of a repeat attack in patients with a healthy left ventricular ejection fraction. The study spanned over several countries, involving more than 5,000 participants, each recovering from an acute myocardial infarction. With eyes on these patients for an average of 3.5 years, the findings were crystal clear: there was no significant advantage to ongoing beta-blocker use in this particular group. This sparks a vital conversation about personalised medicine. Does one-size-fits-all still apply in the era of targeted therapies? As the data unfolds, it becomes increasingly clear that custom-fit treatment could be the future of cardiac care. It's about more than just managing the heart attack; it's about managing the individual's overall health landscape. 📊 Share your thoughts - could this pave the way for a whole new approach in cardiology? #CardiacCare #HeartHealth #BetaBlockers

The burden of heart failure is significant. As part of ▶️Heart Failure Awareness Week◀️ we’d like to help bring visibility to this unmet need, educate about the patient experience, and raise awareness of efforts to improve prevention and treatment by encouraging you to check out our recent webinar discussion with experts in heart failure clinical research. During the discussion, they share case studies of using sensor-based digital health technologies (DHTs) to remotely obtain and analyze real-world, clinically meaningful data and how that is informing their work to develop treatments for heart failure. Whether you’re conducting research in heart failure or are impacted by heart failure, this is an informative and optimistic discussion about efforts to improve the lives of those with heart failure. #HFWeek2024 #heartfailure #cliincalresearch #digitalhealthtechnology ⏩Watch here: https://hubs.la/Q02lcPc80

🚨 PUBLICATION ALERT 🚨 Excited to share our latest research published in Heart Rhythm Journal! Our study delved into the relationship between socioeconomic status and outcomes for patients hospitalized with complete heart block. Key findings: - Patients from lower-income areas were less likely to receive early permanent pacemaker intervention - Lower income was associated with higher in-hospital mortality and adverse outcomes - Gender disparities were observed, with women having higher odds of mortality This work sheds light on crucial disparities in care and outcomes, aiming to be part of the efforts towards enhancing equity in cardiovascular care delivery. #HealthEquity #Cardiology #HeartRhythm Nadhem Abdallah Hennepin Healthcare GME https://lnkd.in/gQ7Q-vt2

Heart failure (HF) is a major public health concern that affects 2-3% of adults in high-income countries. A research was conducted by JAMA Cardiology to determine whether activation of β3-Adrenergic Receptors (β3AR) by repurposing a β3AR agonist, mirabegron, is safe and effective in preventing progression of Left Ventricular (LV) hypertrophy and diastolic dysfunction among patients with pre or mild HF. Click here to read the results of the research: https://lnkd.in/d7p82NYd #HeartFailureRate #HeartFailureResearch #MedicalResearch #MedicalResearchPaper #JournalCoverage #ExploreMedicine #CaseReport #TerumoJournal #TerumoJournalCoverage #InterventionalCardiology #InterventionalRadiology #Terumo #TerumoIndiaSkillLab

A groundbreaking study published in the American Heart Association journal Circulation has uncovered a startling truth: patients in their 50s with severe peripheral artery disease (PAD) face a higher risk of major amputation than older individuals, even after undergoing emergency revascularization. This unexpected finding challenges the conventional understanding of PAD and highlights the critical importance of early detection and treatment in younger populations. Don't let age be a misleading factor – screen your patients for PAD early and often to prevent devastating limb loss. Key Takeaways from the Study: Age Isn't Everything: The research shows that the risk of amputation was significantly higher for younger adults (50-54) who had emergency revascularization, compared to those aged 80-84. Early Detection is Key: The study's lead author emphasizes that "better preventive strategies are warranted" for younger patients with severe PAD. Rethink Your Approach: Dr. Venita Chandra, a vascular surgeon at Stanford University, urges physicians to consider PAD in younger patients and not wait until the disease has progressed to an advanced stage before intervening. This groundbreaking research underscores the need for a paradigm shift in how we approach PAD. Don't underestimate the impact of PAD in younger patients. Prioritize early screening and aggressive treatment to prevent amputation and improve patient outcomes. Read more here: https://bit.ly/46gk87K #PAD #VascularHealth #Physicians #EarlyDiagnosis #PreventAmputations #Research

To balloon or not to balloon? Time is crucial in treating heart attacks and Percutaneous Coronary Intervention (PCI) - colloquially known as stenting or “ballooning” - is a minimally invasive procedure vital for the treatment of cardiac arrests. However, it may pose health risks for seniors aged 80 and above. In a comprehensive analysis, our NUHCS research team reviewed data from 132 articles across 33 regions. Despite heightened risks, evidence supports the necessity of PCI for treating unstable coronary artery diseases (CAD). This systematic review, conducted in collaboration with geriatric medicine experts, provides clarity for advising older patients on PCI considerations. Read on for more in the NUHCS Pulse Magazine: https://lnkd.in/dAkP32X6 #NUHCS #PCI #Cardiology #HeartHealth #MedicalResearch